184 related articles for article (PubMed ID: 32812222)
1. Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review.
Onuoha C; Barton KD; Wong ECC; Raval JS; Rollins-Raval MA; Ipe TS; Kiss JE; Boral LI; Adamksi J; Zantek ND; Onwuemene OA
Transfusion; 2020 Nov; 60(11):2714-2736. PubMed ID: 32812222
[TBL] [Abstract][Full Text] [Related]
2. A population-based analysis on the use of therapeutic plasma exchange and intravenous immunoglobulin in heparin-induced thrombocytopenia.
Soares Ferreira Júnior A; Boyle SH; Kuchibhatla M; Onwuemene OA
Thromb Res; 2021 May; 201():6-14. PubMed ID: 33621860
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin-induced thrombocytopenia.
Moreno-Duarte I; Cooter M; Onwuemene OA; Ghadimi K; Welsby IJ
Vox Sang; 2021 Feb; 116(2):217-224. PubMed ID: 32965049
[TBL] [Abstract][Full Text] [Related]
4. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
Dougherty JA; Yarsley RL
Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.
Onwuemene OA; Zantek ND; Rollins-Raval MA; Raval JS; Kiss JE; Ipe TS; Kuchibhatla M; Pagano MB; Wong ECC
J Clin Apher; 2019 Oct; 34(5):545-554. PubMed ID: 31116461
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of intravenous immunoglobulin use in heparin-induced thrombocytopenia.
Aryal MR; Gosain R; Donato A; Katel A; Chakradhar R; Dhital R; Kouides PA
Blood Coagul Fibrinolysis; 2020 Jul; 31(5):287-292. PubMed ID: 32398463
[TBL] [Abstract][Full Text] [Related]
7. Perioperative Plasma Exchange and Intravenous Immunoglobulin Use for Refractory Heparin-Induced Thrombocytopenia in a Liver Transplant Recipient.
Habibi S; Hsieh TC; Khanna S
Am J Case Rep; 2023 Dec; 24():e941865. PubMed ID: 38158651
[TBL] [Abstract][Full Text] [Related]
8. Use of therapeutic plasma exchange in heparin-induced thrombocytopenia: A population-based study.
Soares Ferreira Júnior A; Boyle SH; Kuchibhatla M; Akinyemiju T; Onwuemene OA
J Clin Apher; 2021 Jun; 36(3):398-407. PubMed ID: 33453132
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange for heparin-induced thrombocytopenia in patients on extracorporeal circuits: A challenging case and a survey of the field.
Cho JH; Parilla M; Treml A; Wool GD
J Clin Apher; 2019 Feb; 34(1):64-72. PubMed ID: 30407650
[TBL] [Abstract][Full Text] [Related]
10. Cardiac surgery in acute heparin-induced thrombocytopenia managed with therapeutic plasma exchange and intravenous immunoglobulin.
Grazioli A; Splinter NP; Plazak ME; Griffith BP; Dahi S; Bathula AH; Cheung NH; Padmanabhan A
Res Pract Thromb Haemost; 2023 Feb; 7(2):100089. PubMed ID: 37063753
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia.
Park BD; Kumar M; Nagalla S; De Simone N; Aster RH; Padmanabhan A; Sarode R; Rambally S
Transfus Apher Sci; 2018 Aug; 57(4):561-565. PubMed ID: 30244713
[TBL] [Abstract][Full Text] [Related]
12. IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.
Padmanabhan A; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Bryant BJ; Alperin JB; Deloughery TG; Mulvey KP; Dhakal B; Wen R; Wang D; Aster RH
Chest; 2017 Sep; 152(3):478-485. PubMed ID: 28427966
[TBL] [Abstract][Full Text] [Related]
13. High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review.
Warkentin TE
Expert Rev Hematol; 2019 Aug; 12(8):685-698. PubMed ID: 31274032
[No Abstract] [Full Text] [Related]
14. High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response.
Winder A; Shoenfeld Y; Hochman R; Keren G; Levy Y; Eldor A
J Clin Immunol; 1998 Sep; 18(5):330-4. PubMed ID: 9793825
[TBL] [Abstract][Full Text] [Related]
15. Bleeding is associated with intravenous immunoglobulin and therapeutic plasma exchange use in heparin-induced thrombocytopenia: A propensity matched analysis.
Soares Ferreira Júnior A; Boyle SH; Kuchibhatla M; Onwuemene OA
EJHaem; 2021 Aug; 2(3):466-470. PubMed ID: 35844687
[TBL] [Abstract][Full Text] [Related]
16. Refractory heparin induced thrombocytopenia with thrombosis (HITT) treated with therapeutic plasma exchange and rituximab as adjuvant therapy.
Schell AM; Petras M; Szczepiorkowski ZM; Ornstein DL
Transfus Apher Sci; 2013 Oct; 49(2):185-8. PubMed ID: 23419837
[TBL] [Abstract][Full Text] [Related]
17. The Triple HIT: Perioperative Management of Heparin-Induced Thrombocytopenia Using Plasma Exchange, Intravenous Immunoglobulin, and Protamine Infusion for Left Ventricular Assist Device Implantation.
Liu VC; Klompas AM; Stulak JM; Yalamuri SM
J Cardiothorac Vasc Anesth; 2022 Jun; 36(6):1715-1719. PubMed ID: 33933367
[TBL] [Abstract][Full Text] [Related]
18. Use of plasma exchange in patients with heparin-induced thrombocytopenia: a report of two cases and a review of the literature.
Jaben EA; Torloni AS; Pruthi RK; Winters JL
J Clin Apher; 2011; 26(4):219-24. PubMed ID: 21506142
[TBL] [Abstract][Full Text] [Related]
19. Early high-dose intravenous immunoglobulin for refractory heparin-induced thrombocytopenia with stroke: Two case reports.
Makita N; Ohara T; Tsuji Y; Ueda T; Nakamura T; Mizuno T; Makino M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107032. PubMed ID: 36701852
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative therapeutic plasma Exchange and intravenous immune globulin for the treatment of heparin induced thrombocytopenia in a lung transplant recipient.
Mandernach MW; Nandavaram S; Salame B; Machuca T; Pelaez A
Transfus Apher Sci; 2019 Aug; 58(4):505-507. PubMed ID: 31387833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
